Buying this stock

Let me confess something to you.

Before I started writing Compounding Quality, I owned Novo Nordisk.

I owned the company between 2019 and 2023 and sold it because I thought Novo Nordisk was too expensive. I made a +200% profit.

But guess what? Today, Novo Nordisk’s stock price declined by 40% compared to 2023, while its intrinsic value increased by 40%.

So …